Total Results: 15738

Va. Report Identifies Ways To Cut Millions From Annual Medicaid Budget

KHN Morning Briefing

The report by the state’s Joint Legislative Audit and Review Commission recommends tightening the cap on profits and increasing oversight of insurers in the program. Meanwhile, in Kansas, reversing a 4 percent emergency budget cut is a priority.

Hospitals’ Safety Measure Improvements Prevent 125,000 Deaths, Save $28M

KHN Morning Briefing

A Department of Health and Human Services report finds that those patient safety efforts also prevented 3.1 million hospital-acquired conditions from 2010 to 2015. In other news, the Centers for Medicare & Medicaid Services issues an interim rule that takes aim at providers that steer patients eligible for Medicare or Medicaid into private insurance in order to receive higher reimbursement rates.

Trump Faces Pressure From Vets’ Group To Keep McDonald In VA’s Top Spot

KHN Morning Briefing

The nation’s largest veterans’ organizations urge President-elect Donald Trump to keep Robert McDonald on as Secretary of Veterans Affairs out of concern that some of the rumored candidates for the job would not be a good fit. In other news, Reuters reports on Scott Gottlieb, a former Food and Drug Admnistration deputy commissioner, who is among those being considered to lead the FDA.

Which Drugs Hit Taxpayers’ Wallets The Hardest?

KHN Morning Briefing

CMS releases the list of drugs that contributed to higher Medicare spending in 2015. Meanwhile, payers predict drug prices will continue to rise between 3 and 6 percent over the next three years.

Biogen Learns Lessons From Lilly’s Failed Alzheimer’s Drug

KHN Morning Briefing

Meanwhile, in other pharmaceutical news, the U.S. solicitor general urges the Supreme Court to review a case on biosimilars. And news outlets report on developments from Bristol-Myers, Horizon Pharma and Endo International.

With Pledge To Take On Drug Prices, Trump Dashes Pharma’s Hopes

KHN Morning Briefing

The industry breathed a sigh of relief after avoiding a Hillary Clinton presidency, but Donald Trump still remained a question mark. In an interview with Time Magazine, though, the president-elect said he is “going to bring down drug prices.” Stocks fell despite a lack of details on how that will be accomplished.